NATCOPHARM

Faces Resistance Upside Attempts Losing Momentum

appear technically bearish as the stock struggles to sustain above the key resistance zone near ₹1,000–₹1,020. The chart shows repeated rejections around this level, indicating strong selling pressure from higher levels. Although the RSI is around the mid-50s suggesting moderate momentum, the price action reflects a pattern of lower highs, which signals underlying weakness. In my view, if the stock fails to hold above ₹1,000, it could witness renewed selling pressure and may drift toward the ₹920–₹900 support zone in the near term as sellers continue to dominate the trend.